Steroids in Occipital Nerve Block for Treatment of Headache
Headache, Occipital Nerve Block
About this trial
This is an interventional treatment trial for Headache
Eligibility Criteria
Inclusion Criteria: Treated for headache including but not limited to occipital neuralgia, episodic migraine, chronic migraine and/or cervicogenic headache. Stable on preventative medication dosing for at least 1 month prior to occipital nerve block and no change in preventative medication regimen during the course of the study. Able to understand the requirements of the study and return for treatment. Able to independently provide informed consent. Exclusion Criteria: Diagnosis of cluster headache according to the International Classification of Headache Disorders 3rd edition. Occipital or other cranial nerve block administered within 3 months prior to initiation of study. History of adverse reaction or contraindication to any of the study ingredients (bupivacaine, lidocaine, dexamethasone). Pregnancy. Infection or bleeding at site of injection. Cranial bone or cervical spine defects/prior surgeries near injection site that prohibit use of landmark-based technique.
Sites / Locations
- Mayo Clinic MinnesotaRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Anesthetic without steroid group
Anesthetic with dexamethasone group
Subjects scheduled for bilateral greater/lesser occipital nerve blocks as part of clinical care will receive standard of care medication, including lidocaine and bupivacaine and normal saline.
Subjects scheduled for bilateral greater/lesser occipital nerve blocks as part of clinical care will receive standard of care medication, including lidocaine and bupivacaine and dexamethasone.